GCG and type 2 diabetes mellitus: In patients with MS and T2DM, GLP-1 restored insulin sensitivity, improved glycemic control, reduced the oxidative stress and prevented the disturbances in the cardiovascular system, which makes GLP-1 and its analogs the promising drugs to treat these diseases [321–324].